Important Information

AMP 2013 Annual Meeting
November 14-16, 2013
Phoenix Convention Center
Phoenix, AZ
Corporate Workshop Day
November 13, 2013
Visit Meeting Page

AMP 2013 MGP Review Course
April 4-7, 2013
Double Tree by Hilton Hotel
Bethesda - Washington DC
Visit Course Page

Special Features

AMP International
AMP Test Directory
Awards, Grants & Honors
Career Development
Membership Information
Online Member Directory
The Journal of Molecular Diagnostics
Trainee Programs
Web Library

How to Help

Corporate Support Opportunities
Donate to AMP
Volunteer

more information

Advocacy Home Page

AMP Press Releases

AMP Position Statements and Letters

• Home
• 2013

• 2012

• 2011
• 2010
• 2009
• 2008
• 2007
• 2006 & Earlier

 

AMP Position statements and letters

AMP Position Statements and Letters - 2008

 

2008	Title	Keywords	Committee
December	Letter to the WHO endorsing reference materials for fragile X and other molecular tests		Clinical Practice
November	Gene Patents and the Exclusive Licensing of Genetic Discoveries		Professional Relations
September	Comments to CMS regarding MUEs		Economic Affairs
	Comments to CMS regarding PGx Testing of Warfarin Response		Economic Affairs
	Comments to Florida Board of Clinical Lab Personnel regarding Licensure Requirements for Molecular Pathology Technologists		Clinical Practice
July	Suggestions to the SACGHS regarding New Priorities		Professional Relations
April	Comments to FDA regarding Guidance on PGx Data Submissions		Clinical Practice
	Comments to FDA regarding Guidance on Definitions for PGx and Sample Coding Categories		Clinical Practice
	Comments to NIGMS regarding barriers to PGx research		Clinical Practice
March	Comments to NACB regarding Guidelines for Lab Analysis and Application of PGx to Clinical Practic		Clinical Practice
	Comments to EMEA regarding Guidance on Definitions for PGx and Sample Coding Categories		Clinical Practice
February	Verbal Comments to the SACGHS Regarding Oversight of Genetic Testing Draft Report		Professional Relations